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Are Our Tools for the Identiﬁcation of TCFA Ready and
Do We Know Them?*
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VThe current understanding of the cause of acute
coronary syndromes is that most result from plaque
rupture of a vulnerable plaque. The word “vulner-
able” plaque was coined by Muller et al. (1) to
define lesions that underlie luminal thrombosis.
The definition was further clarified by Libby (2) to
include fibrous cap infiltration by macrophages and
T-lymphocytes at shoulder regions of the plaque;
the latter release interferon-gamma, which suppress
collagen deposition by smooth muscle cells, whereas
See pages 638 and 647
the former secrete matrix metalloproteinases de-
grading collage fibers with subsequent plaque rup-
ture. In 1997 Burke et al. (3) defined vulnerable
plaques (thin-cap fibroatheromas [TCFA]) as le-
sions with a fibrous cap 65 m with macrophage
infiltration (25 cells/high-magnification [0.3 mm
diameter] field) and an underlying necrotic core.
Subsequently, we showed that TCFA had a signif-
icantly smaller necrotic core and less macrophage
infiltration of the fibrous cap than ruptured plaques
(4) (Fig. 1). Since the 1980s, it has been appreciated
that plaque progression is associated with positive
remodeling (5) and that the highest remodeling
index is seen in plaque ruptures (6). Plaque ruptures
and TCFA tend to occur at proximal locations of
the coronary arteries (4). Therefore, accurate iden-
tification of these vulnerable lesions has become the
“holy grail” of interventional cardiology with the
idea that, if we could identify these sites before
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vascular Imaging or the American College of Cardiology.
From CVPath Institute, Inc., Gaithersburg, Maryland. Dr. Virmani has
relationships with Abbott Vascular, Arsenal Medical, Atrium Medicalt
Corp., Biosense International, GlaxoSmithKline, Lutonix, Medtronic
Ave, and W.L. Gore.upture, we could then treat them by interventional
eans or even medically to prevent clinical events,
educing both morbidity and mortality.
Many invasive and noninvasive imaging modali-
ies have been introduced to identify the TCFA.
ntravascular ultrasound (IVUS) (resolution ap-
roximately 200 m) for plaque area and volume
easurement has been around for a long time;
owever, although it does characterize calcified
reas, it has limited capability to identify “necrotic
ore” and “lipid pools” (7). Recently, 2 new tech-
iques that use ultrasound-based radiofrequency
ignals (virtual histology [VH]) and integrated
ackscatter (IB) values have characterized the
laque areas that contain “necrotic core” or “lipid
ool”; dense fibrosis or fibrosis; fibrofatty or fibrosis;
nd dense calcification or calcification, respectively
8,9). Some investigators (10) claim that the latter
rovides higher accuracy than the former. Another
echnique, optical coherence tomography (OCT),
ith a resolution of 15 to 20 m, has the ability to
easure coronary microstructure including fibrous
ap thickness65 m and macrophage infiltration;
owever, it has limited depth of penetration (1.0 to
.5 cm) (11,12). Because the presence of necrotic
ore is an important component of TCFA, near-
nfrared spectroscopy—which has otherwise been
sed to determine chemical composition of sub-
tances—seems highly suitable to identify choles-
erol ester and free cholesterol and is available in
n intravascular catheter system (13).
Having been involved at some stage of the
ntroduction of these catheter-based new technolo-
ies, I believe it is important to critically examine
hether any or all of them are capable of identifying
CFA, a lesion that we all believe as a critical
redecessor of plaque rupture. Let us first discuss
H-IVUS, which was introduced in 2002. I believehere is oversimplification of manner by which the
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657TCFA is recognized with this modality. Because
the resolution is 150 to 200 m, it is incapable of
identifying the fibrous cap thickness component of
TCFA (i.e., 65 m). How accurate is the tech-
ology for the identification of “necrotic core?” I
elieve its accuracy in separating “lipid pool” from
necrotic core” is questionable, as there is a fair
mount of overlap. This separation is critical to
alling a lesion “fibroatheroma” or TCFA, because
ecrotic core (not lipid pool) is a critical feature.
nother IVUS-based technology, IB-IVUS, simi-
arly lacks resolution, because it cannot identify
thin cap” of TCFA, and it too does not separate
lipid pool” from “necrotic core.” It also likely
over-calls” areas of lipid-rich lesion and, therefore,
he percent lipid pool area is significantly larger
han what is actually present in the lesions.
By contrast, there is no question that OCT is far
uperior (10 to 20 m), from the point of resolution
nd, therefore, can identify thin caps of TCFA.
owever, it is not always easy to separate “calcified
rea” from “necrotic core,” because it is dependent
n attenuation of the signals (i.e., abrupt for cal-
ium vs. gradual for “necrotic core”); in experienced
ands I believe this should not be such a problem.
owever, OCT is unable to give us vessel dimen-
ions, plaque area, or “necrotic core” area, because
Figure 1. Photomicrographs of Plaque Rupture and Thin-Cap Fi
Plaque rupture (A and B) and thin-cap ﬁbroatheroma (C and D). Bo
by macrophages; B is rupture site, and D shows intact ﬁbrous cap.f limitation of depth penetration of the vessel wall. phese parameters (i.e., vessel remodeling as well as
laque area), can be assessed by IVUS, VH, and
B-IVUS though as indicated, both likely overesti-
ate lipid core area and may have limited capability
or assessing vulnerability index.
Near-infrared spectroscopy is not image-based
ut assesses presence of cholesterol monohydrate
nd cholesterol ester, which are high in necrotic
ores, as reported by Mann and Davies (14) in
isrupted plaques. Near-infrared spectroscopy gives
“chemogram,” and in validation studies “fibro-
theromas” were defined as representing lesions
ith a lipid core of 60° in circumference and
200 m. It has the limitation that it does not
easure fibrous cap; therefore, it too cannot sepa-
ate fibroatheromas from TCFA. However, its abil-
ty to recognize presence of free cholesterol is far
uperior to IVUS- or OCT-based techniques.
herefore, none of the technologies available indi-
idually gives us great confidence of their ability to
etect presence of TCFA with the accuracy that is
equired to make inroads into the prevention of
cute coronary syndrome.
Let us assume that a combination of devices
etect presence of TCFA with certain accuracy, and
f so, we need to understand as to what we are likely
o gain. It has long been appreciated that plaque
atheroma
areas in A and C show the thin ﬁbrous cap, which is inﬁltratedbro
xedrogression beyond 50% cross-sectional area nar-
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658rowing in a vast majority of cases occurs through
repeated rupture, which occur silently (15). Mann
and Davies (14) in the late 1990s showed that
healed plaque ruptures were most frequently seen in
lesions with diameter stenosis 50% (73%). We
showed that the incidence of healed rupture was
highest in stable plaques with healed myocardial
infarction, followed by acute ruptures, and least in
stable plaque without a healed myocardial infarction
(80%, 75%, 53%, respectively) (15). Healed and
acute ruptures are most frequently located at
proximal, followed by middle, and least fre-
quently located in distal coronary arteries. Also,
the luminal narrowing increased with increasing
number of healed plaque ruptures. Only 11% of
cases with acute rupture had not had a previous
rupture site (i.e., virgin ruptures) (15). Therefore,
it is clear that not all plaque ruptures will lead to
clinical symptomatology.
Therefore, for further understanding of plaque2002;105:297–303.
1
1
1
coherence tomogrvulnerable (i.e., TCFA) and follow these patients
for symptom development and also re-interrogate
the lesion at a specified time (1 to 2 years) to
determine what number would have ruptured either
silently or producing symptoms. The most impor-
tant morphology for the identification of TCFA
is the presence of a large necrotic core, thin
fibrous cap, and positive remodeling; and if we
can have everything, then I would certainly add
macrophage infiltration of the fibrous cap and
angiogenesis. Until we are able to identify TCFA
with a high sensitivity and specificity, we will fail
in our endeavor to understand how plaque evo-
lution leads to symptom development and plaque
progression, because both are essential if we are
to treat patients who have vulnerable lesions
along with risk factors (14).
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